DRUGS MADE IN AMERICA ACQUIS (DMAA) Stock Technical Analysis
NASDAQ:DMAA • KYG2847J1040
Overall DMAA gets a technical rating of 7 out of 10. This is due to a decent performance in both the short and medium term time frames. Compared to the overall market, DMAA is only an average performer.
- Both the short term and long term trends are positive. This is a very positive sign.
- DMAA is currently trading near its 52 week high, which is a good sign. The S&P500 Index however is also trading near new highs, which makes the performance in line with the market.
- When compared to the yearly performance of all other stocks, DMAA outperforms 48% of them, which is more or less in line with the market.
- In the last month DMAA has a been trading in a tight range between 10.41 and 10.48.
- Volume is considerably higher in the last couple of days.
DMAA has an excellent technical rating, but the quality of the setup is only medium at the moment. Price movement has been a little bit too volatile to find a nice entry and exit point. It is probably a good idea to wait for a consolidation first.
More info and screens
10.12
We found 1 important support area.
- A support zone ranging from 10.22 to 10.45. This zone is formed by a combination of multiple trend lines and important moving averages in multiple time frames.
When analyzing the resistance we notice one important area.
- A resistance zone ranging from 10.47 to 10.49. This zone is formed by a combination of multiple trend lines in multiple time frames.
The Technical Rating and Setup analysis above combine different indicators and trends in different timeframes. Individual signals from indicators may give more contradictive signals and should always be interpreted in the more global context.
| Indicator | Value | Signal | Comment |
|---|---|---|---|
| ChartMill Long Term Trend Indicator | UP | POSITIVE | The long term trend for DMAA is up. |
| ChartMill Short Term Trend Indicator | UP | POSITIVE | The short term trend for DMAA is up. |
| ChartMill Relative Strength | 48.72 | NEUTRAL | DMAA is not amongst the best or worst performers on the market. |
| Simple Moving Average/SMA (20) | UP | POSITIVE | The current price of DMAA is above the rising SMA(20). |
| Simple Moving Average/SMA (50) | UP | POSITIVE | The current price of DMAA is above the rising SMA(50). |
| Simple Moving Average/SMA (200) | UP | POSITIVE | The current price of DMAA is above the rising SMA(200). |
| Relative Strength Index/RSI (14) | 58.07 | NEUTRAL | The RSI value for DMAA is a neutral value. |
| Moving Average Convergence Divergence/MACD (12, 26, 9) | 0 | POSITIVE | The MACD value suggests DMAA has a positive trend, although the MACD value is declining. |
| Stochastics (14,3) | 86.67 | OVERBOUGHT | The high Stochastics value suggests DMAA may be overbought. |
| Average True Range in percent/ATR (20) | 0.17 | LOW VOLATILITY | The low ATR as a percentage value for DMAA suggests low volalility. |
| Average Directional Index/ADX (14) | 40.53 | POSITIVE | The high ADX value value for DMAA suggests a strong trend. |
NASDAQ:DMAA (2/27/2026, 8:00:02 PM)
10.46
-0.02 (-0.19%)
DRUGS MADE IN AMERICA ACQUIS / DMAA FAQ
What is the technical rating for DMAA stock?
ChartMill assigns a technical rating of 7 / 10 to DMAA.
Can you provide the trend direction for DRUGS MADE IN AMERICA ACQUIS?
The current trend direction for DRUGS MADE IN AMERICA ACQUIS (DMAA) is Bullish.
What is the RSI signal for DRUGS MADE IN AMERICA ACQUIS (DMAA) stock?
DRUGS MADE IN AMERICA ACQUIS (DMAA) has an RSI value of 58.0738. This indicates that the stock is currently neutral.
What is the short term momentum for DMAA stock?
The short term momentum for DRUGS MADE IN AMERICA ACQUIS (DMAA) is positive.
What is the buy/sell signal for DRUGS MADE IN AMERICA ACQUIS (DMAA) stock?
The buy/sell signal for DRUGS MADE IN AMERICA ACQUIS (DMAA) is buy as both the short term and long term trends are positive.